ER 50891 quarterhydrate is a potent and selective RARalpha antagonist. It effectively counteracts the suppression of BMP2-induced osteoblastogenesis by ATRA, making it a valuable research tool for studying retinoid signaling in bone biology, both in vitro and in vivo.
Molecular Weight:
437.02
Formula:
C29H24N2O2.1/4H2O
Target:
Others,Retinoid Receptor
* VAT and and shipping costs not included. Errors and price changes excepted